The prognostic value of erythrocyte sedimentation rate in all-cause mortality of patients with idiopathic pulmonary fibrosis: Based on inpatient hospital records
Therapeutic Advances in Respiratory Disease · 2026-10 · 20
DOI: 10.1177/17534666261504320 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Advances in Respiratory Disease, online erschienen am 02.11.2026. Verfasst von Aiyuan Zhou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, National Key Clinical Specialty, Branch of National Clinical Research Center for Respiratory Disease, Xiangya Hos…. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis, Blood Sedimentation. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Idiopathic pulmonary fibrosis (IPF) is a chronic progressive interstitial lung disease with a high mortality rate. Reliable biomarker can enable clinicians to judge the development and prognosis of IPF.
Objectives
This study aimed to investigate the prognostic value of erythrocyte sedimentation rate (ESR) for predicting all-cause mortality in IPF.
Design
This retrospective cohort study enrolled patients hospitalized with IPF between January 1st, 2015 and May 31st, 2023.
Methods
Data was collected regarding patient demographics, laboratory analysis results, and the following pulmonary function parameters: the forced expiratory volume in one second percentage of predicted (FEV1 %pred), forced vital capacity percentage of predicted (FVC %pred), diffusing capacity divided by the alveolar volume (DLCO/VA), DLCO, DLCO %pred. All-cause mortality data were collected throughout the 18 months follow-up period.
Results
A total of 510 IPF patients recruited for the final analysis, 131 (25.7%) died during follow-up. IPF patients who died were older, had a higher white blood cell, lactic dehydrogenase, fibrinogen and ESR. In addition, IPF patients who died had a worse pulmonary function, as evidenced by lower FEV1 %pred, FVC %pred, DLCO %pred and DLCO/VA (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory Medicine, National Key Clinical Specialty, Branch of National Clinical Research Center for Respiratory Disease, Xiangya Hospital, Central South University, Changsha, Hunan, China.
- Center of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China.
- Department of Respiratory Medicine, Clinical Research Center for Respiratory Diseases in Hunan Province, Changsha, Hunan, China.
- Hunan Engineering Research Center for Intelligent Diagnosis and Treatment of Respiratory Disease, Changsha, Hunan, China.
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, Hunan, P.R. China.
- Postdoctoral Innovation Practice Base, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, People's Republic of China.
ORCID-Profile: Qing Song, Pinhua Pan
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhou, A., Song, Q., Deng, D., Zhang, X., & Pan, P. (2026). The prognostic value of erythrocyte sedimentation rate in all-cause mortality of patients with idiopathic pulmonary fibrosis: Based on inpatient hospital records. Therapeutic Advances in Respiratory Disease, 20. https://doi.org/10.1177/17534666261504320
Vancouver
Zhou A, Song Q, Deng D, Zhang X, Pan P. The prognostic value of erythrocyte sedimentation rate in all-cause mortality of patients with idiopathic pulmonary fibrosis: Based on inpatient hospital records. Therapeutic Advances in Respiratory Disease. 2026;20. doi:10.1177/17534666261504320
BibTeX
@article{Zhou2026,
author = {Zhou, Aiyuan and Song, Qing and Deng, Dingding and Zhang, Xiyan and Pan, Pinhua},
title = {The prognostic value of erythrocyte sedimentation rate in all-cause mortality of patients with idiopathic pulmonary fibrosis: Based on inpatient hospital records},
journal = {Therapeutic Advances in Respiratory Disease},
year = {2026},
volume = {20},
doi = {10.1177/17534666261504320}
}
EUVIMED